Garlic in Patients With Febrile Neutropenia

Status Recruiting

Clinical Trial Summary

To determine the clinical effects of garlic in preventing and treatment of patients with chemotherapy related febrile neutropenia.These patients have a very high incidence of infections which are not routinely covered by the standard empiric therapy. Adding a non- toxic and possibly effective therapy may reduce the risk for infections, synergize the empiric antibiotic treatment and may lessen the need for broader spectrum and more severe side effects.

Clinical Trial Description

Patients eligible are randomized to receive placebo or garlic capsules after chemotherapy course and until leukocyte recovery. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00247039
Study type	Interventional
Source	Hadassah Medical Organization
Contact	moshe e gatt, dr
Phone	972-50-5172333
Email	dr.mgatt@gmail.com
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	June 2006
Completion date	August 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02452034` - Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)	Phase 1
Not yet recruiting	`NCT02806557` - Profiling Neutrophil Counts in Patients on Chemotherapy	N/A
Not yet recruiting	`NCT01714557` - Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation	N/A
Completed	`NCT01371656` - Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation	Phase 3
Active, not recruiting	`NCT00020865` - Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia	Phase 3
Completed	`NCT00257790` - The Tobramycin Study	Phase 4
Completed	`NCT00020371` - BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy	Phase 1
Terminated	`NCT00005787` - Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma	Phase 1
Completed	`NCT00001533` - Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine	Phase 1
Completed	`NCT05585463` - Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)
Not yet recruiting	`NCT02238873` - Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma	Phase 3
Completed	`NCT01058993` - AMD 3100 for Treatment of Myelokathexis	Phase 1
Completed	`NCT00771810` - Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer	Phase 2
Completed	`NCT00770172` - G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy	Phase 3
Completed	`NCT00771433` - G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer	Phase 2
Terminated	`NCT00529282` - A Study of Ceftobiprole in Patients With Fever and Neutropenia.	Phase 3
Active, not recruiting	`NCT00030758` - Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer	Phase 4
Completed	`NCT00001790` - Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia	Phase 1
Completed	`NCT00002693` - Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia	Phase 1
Active, not recruiting	`NCT04154488` - A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders	Phase 1/Phase 2